|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar
|
|
2
|
Yeo TP, Hruban RH, Leach SD, et al:
Pancreatic cancer. Curr Probl Cancer. 26:176–275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Husain SS, Szabo IL and Tamawski AS: NSAID
inhibition of GI cancer growth: clinical implications and molecular
mechanisms of action. Am J Gastroenterol. 97:542–553. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stan SD, Singh SV and Brand RE:
Chemoprevention strategies for pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 7:347–356. 2010.PubMed/NCBI
|
|
5
|
Jacobs EJ, Connell CJ, Rodriguez C, Patel
AV, Calle EE and Thun MJ: Aspirin use and pancreatic cancer
mortality in a large United States cohort. J Natl Cancer Inst.
96:524–528. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuo ML, Huang TS and Lin JK: Curcumin, an
antioxidant and anti-tumor promoter, induces apoptosis in human
leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shishodia S, Amin HM, Lai R and Aggarwal
BB: Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB
activation, induces G1/S arrest, suppresses proliferation, and
induces apoptosis in mantle cell lymphoma. Biochem Pharmacol.
70:700–713. 2005. View Article : Google Scholar
|
|
8
|
Matusheski NV, Juvik JA and Jeffery EH:
Heating decreases epithiospecifier protein activity and increases
sulforaphane formation in broccoli. Phytochemistry. 65:1273–1281.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim BR, Hu R, Keum YS, et al: Effects of
glutathione on antioxidant response element-mediated gene
expression and apoptosis elicited by sulforaphane. Cancer Res.
63:7520–7525. 2003.PubMed/NCBI
|
|
10
|
Chang F, Lee JT, Navolanic PM, et al:
Involvement of PI3K/Akt pathway in cell cycle progression,
apoptosis, and neoplastic transformation: a target for cancer
chemotherapy. Leukemia. 17:590–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pearson G, Robinson F, Beers Gibson T, et
al: Mitogen-activated protein (MAP) kinase pathways: regulation and
physiological functions. Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
12
|
Adachi T, Kar S, Wang M and Carr BI:
Transient and sustained ERK phosphorylation and nuclear
translocation in growth control. J Cell Physiol. 192:151–159. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chaudhary A, Sutaria D, Huang Y, Wang J
and Prabhu S: Chemoprevention of colon cancer in a rat
carcinogenesis model using a novel nanotechnology-based combined
treatment system. Cancer Prev Res. 4:1655–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Narayanan BA, Narayanan NK, Desai D,
Pittman B and Reddy BS: Effects of a combination of docosahexaenoic
acid and 1,4-phenylene bis(methylene) selenocyanate on
cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin
pathways in colon cancer cells. Carcinogenesis. 25:2443–2449. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Im SR and Jang YJ: Aspirin enhances
TRAIL-induced apoptosis via regulation of ERK1/2 activation in
human cervical cancer cells. Biochem Biophys Res Commun. 424:65–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aoki H, Takada Y, Kondo S, Sawaya R,
Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the
growth of malignant gliomas in vitro and in vivo through induction
of autophagy: role of Akt and extracellular signal-regulated kinase
signaling pathways. Mol Pharmacol. 72:29–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jakubíková J, Sedlák J, Mithen R and Bao
Y: Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane-
and erucin-induced phase II enzymes and MRP2 transcription, G2/M
arrest and cell death in Caco-2 cells. Biochem Pharmacol.
69:1543–1552. 2005.PubMed/NCBI
|
|
19
|
Ou YQ, Zhu W, Li Y, et al: Aspirin
inhibits proliferation of gemcitabine-resistant human pancreatic
cancer cells and augments gemcitabine-induced cytotoxicity. Acta
Pharmacol Sin. 31:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim JH, Xu C, Keum YS, Reddy B, Conney A
and Kong AN: Inhibition of EGFR signaling in human prostate cancer
PC-3 cells by combination treatment with beta-phenylethyl
isothiocyanate and curcumin. Carcinogenesis. 27:475–482. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pham NA, Jacobberger JW, Schimmer AD, Cao
P, Gronda M and Hedley DW: The dietary isothiocyanate sulforaphane
targets pathways of apoptosis, cell cycle arrest, and oxidative
stress in human pancreatic cancer cells and inhibits tumor growth
in severe combined immunodeficient mice. Mol Cancer Ther.
3:1239–1248. 2004.
|
|
23
|
Romashkova JA and Makarov SS: NF-kappaB is
a target of AKT in anti-apoptotic PDGF signalling. Nature.
401:86–90. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cardone MH, Roy N, Stennicke HR, et al:
Regulation of cell death protease caspase-9 by phosphorylation.
Science. 282:1318–1321. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu S, Shen G, Khor TO, Kim JH and Kong AN:
Curcumin inhibits Akt/mammalian target of rapamycin signaling
through protein phosphatase-dependent mechanism. Mol Cancer Ther.
7:2609–2620. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Johnson SM, Gulhati P, Arrieta I, et al:
Curcumin inhibits proliferation of colorectal carcinoma by
modulating Akt/mTOR signaling. Anticancer Res. 29:3185–3190.
2009.PubMed/NCBI
|
|
27
|
Chaudhary LR and Hruska KA: Inhibition of
cell survival signal protein kinase B/Akt by curcumin in human
prostate cancer cells. J Cell Biochem. 89:1–5. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bava SV, Puliappadamba VT, Deepti A, Nair
A, Karunagaran D and Anto RJ: Sensitization of taxol-induced
apoptosis by curcumin involves down-regulation of nuclear
factor-kappaB and the serine/threonine kinase Akt and is
independent of tubulin polymerization. J Biol Chem. 280:6301–6308.
2005. View Article : Google Scholar
|
|
29
|
Shankar S, Ganapathy S and Srivastava RK:
Sulforaphane enhances the therapeutic potential of TRAIL in
prostate cancer orthotopic model through regulation of apoptosis,
metastasis, and angiogenesis. Clin Cancer Res. 14:6855–6866. 2008.
View Article : Google Scholar
|
|
30
|
Chaudhuri D, Orsulic S and Ashok BT:
Antiproliferative activity of sulforaphane in Akt-overexpressing
ovarian cancer cells. Mol Cancer Ther. 6:334–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Marshall CJ: Specificity of receptor
tyrosine kinase signaling: transient versus sustained extracellular
signal-regulated kinase activation. Cell. 80:179–185. 1995.
View Article : Google Scholar
|
|
32
|
Chen JR, Plotkin LI, Aguirre JI, et al:
Transient versus sustained phosphorylation and nuclear accumulation
of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J
Biol Chem. 280:4632–4638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang J, Liu X, Bhalla K, et al: Prevention
of apoptosis by Bcl-2: release of cytochrome c from mitochondria
blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
